Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | February 23, 2024 09:06am

Gainers

  • Enveric Biosciences (NASDAQ:ENVB) shares increased by 83.5% to $1.56 during Friday's pre-market session. The company's market cap stands at $4.2 million.
  • Telesis Bio (NASDAQ:TBIO) stock increased by 34.53% to $0.62. The company's market cap stands at $18.4 million.
  • Maravai LifeSciences (NASDAQ:MRVI) shares moved upwards by 27.78% to $6.53. The company's market cap stands at $863.1 million. As per the press release, Q4 earnings came out yesterday.
  • Ocean Biomedical (NASDAQ:OCEA) shares increased by 23.75% to $0.68. The market value of their outstanding shares is at $23.1 million.
  • Nexalin Technology (NASDAQ:NXL) stock increased by 19.35% to $0.37. The market value of their outstanding shares is at $2.6 million.
  • OneMedNet (NASDAQ:ONMD) shares moved upwards by 15.18% to $0.9. The company's market cap stands at $29.0 million.

Losers

  • Venus Concept (NASDAQ:VERO) stock fell 24.2% to $1.41 during Friday's pre-market session. The company's market cap stands at $7.7 million.
  • Biophytis (NASDAQ:BPTS) shares fell 15.24% to $0.45. The company's market cap stands at $4.3 million.
  • Kazia Therapeutics (NASDAQ:KZIA) shares declined by 14.8% to $0.26. The company's market cap stands at $6.7 million.
  • ModivCare (NASDAQ:MODV) shares declined by 12.13% to $38.55. The market value of their outstanding shares is at $546.8 million. As per the news, the Q4 earnings report came out yesterday.
  • Ardelyx (NASDAQ:ARDX) stock declined by 11.91% to $7.77. The market value of their outstanding shares is at $1.8 billion. The company's, Q4 earnings came out yesterday.
  • Rigel Pharmaceuticals (NASDAQ:RIGL) stock decreased by 10.01% to $1.17. The market value of their outstanding shares is at $204.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARDX BPTS ENVB KZIA MODV MRVI NXL OCEA ONMD RIGL TBIO VERO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist